Analyst Price Target is $12.00
▲ +88.68% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $12.00, with a high forecast of $14.00 and a low forecast of $10.00. The average price target represents a 88.68% upside from the last price of $6.36.
Current Consensus is
Buy
The current consensus among 4 polled investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.